This trial is active, not recruiting.

Condition osteoarthritis
Treatment hip surgery
Phase phase 1
Sponsor University of British Columbia
Start date September 2005
End date April 2009
Trial size 156 participants
Trial identifier NCT00175461, C04-0070


Comparison of the clinical effectiveness and cost-effectiveness of the MIS anterolateral approach (MIS Watson Jones, G3) versus anterolateral mini or posterolateral mini approaches in primary total hip arthroplasty

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation non-randomized
Endpoint classification efficacy study
Intervention model single group assignment
Masking open label
Primary purpose treatment

Primary Outcomes

3-months WOMAC score
time frame: 3 months

Secondary Outcomes

Cost-effectiveness at 2-years
time frame: Two years

Eligibility Criteria

Male or female participants at least 19 years old.

Inclusion Criteria: No contralateral hip symptoms, no major comorbidity Exclusion Criteria: -

Additional Information

Official title Comparison of the Clinical Effectiveness and Cost-effectiveness of the MIS Anterolateral Approach (MIS Watson Jones, G3) Versus Anterolateral Mini or Posterolateral Mini Approaches in Primary Total Hip Arthroplasty
Principal investigator Nelson Greidanus, MD
Trial information was received from ClinicalTrials.gov and was last updated in September 2011.
Information provided to ClinicalTrials.gov by University of British Columbia.